Clinical Trial Update: A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic interaction study evaluating the effect of rifampicin on the PK of oral HRS-5041 in healthy subjects has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• HRS-5041
• Rifampicin

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED